NOVEL ANTI-CLAUDIN18 ANTIBODIES

Provided are anti-CLDN18 (in particular, anti-CLDN18.2) antibodies or antigen-binding fragments thereof, isolated polynucleotides encoding the same, pharmaceutical composition comprising the same and the uses thereof.

Saved in:
Bibliographic Details
Main Authors XING, Roumei, YU, Jingfeng, LU, Hongtao, QIU, Yangsheng, GAO, Rui
Format Patent
LanguageEnglish
Published 15.08.2024
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
TESTING
Online AccessGet full text

Cover

Abstract Provided are anti-CLDN18 (in particular, anti-CLDN18.2) antibodies or antigen-binding fragments thereof, isolated polynucleotides encoding the same, pharmaceutical composition comprising the same and the uses thereof.
AbstractList Provided are anti-CLDN18 (in particular, anti-CLDN18.2) antibodies or antigen-binding fragments thereof, isolated polynucleotides encoding the same, pharmaceutical composition comprising the same and the uses thereof.
Author QIU, Yangsheng
YU, Jingfeng
XING, Roumei
LU, Hongtao
GAO, Rui
Author_xml – fullname: XING, Roumei
– fullname: YU, Jingfeng
– fullname: LU, Hongtao
– fullname: QIU, Yangsheng
– fullname: GAO, Rui
BookMark eNrjYmDJy89L5WSQ9_MPc_VRcPQL8dR19nEMdfH0M7QAc538XTxdg3kYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXxosJGBkYmRuYGFsaWjoTFxqgApLSQq
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Physics
ExternalDocumentID US2024270839A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2024270839A13
IEDL.DBID EVB
IngestDate Fri Aug 23 06:53:53 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2024270839A13
Notes Application Number: US202118246516
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240815&DB=EPODOC&CC=US&NR=2024270839A1
ParticipantIDs epo_espacenet_US2024270839A1
PublicationCentury 2000
PublicationDate 20240815
PublicationDateYYYYMMDD 2024-08-15
PublicationDate_xml – month: 08
  year: 2024
  text: 20240815
  day: 15
PublicationDecade 2020
PublicationYear 2024
RelatedCompanies ELPISCIENCE BIOPHARMA, LTD
ELPISCIENCE (SUZHOU) BIOPHARMA, LTD
RelatedCompanies_xml – name: ELPISCIENCE BIOPHARMA, LTD
– name: ELPISCIENCE (SUZHOU) BIOPHARMA, LTD
Score 3.548013
Snippet Provided are anti-CLDN18 (in particular, anti-CLDN18.2) antibodies or antigen-binding fragments thereof, isolated polynucleotides encoding the same,...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
TESTING
Title NOVEL ANTI-CLAUDIN18 ANTIBODIES
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240815&DB=EPODOC&locale=&CC=US&NR=2024270839A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5Kfd40Kj6qFpTcgsm2abKHIHlSpU2KTUpvJUl3QZBaTMS_7-ySak89zizsi52d-WZnZgEeaW_ATD3XNcILigCF61qOB0Xj5pKbpb00CBf5zuN4MMz6r3Nz3oKPTS6MrBP6I4sjokSVKO-1vK_X_06sQMZWVk_FO7I-n6PUCdQGHYt6XYapBp4TTpIg8VXfd7KpGr_JNmKhvUFdxEp7wpAWlfbDmSfyUtbbSiU6gf0J9reqT6HFVgoc-Zu_1xQ4HDdP3gocyBjNskJmI4fVGdzHySwcdd04fdH8kYtGXWzYkvQSYeCdw0MUpv5QwzEXf0tcZNPtCfYuoI3gn11CVwT-sdwiNu5dP88RDTCb2rwoiUV5SegVdHb1dL27-QaOBSl8pIbZgXb99c1uUcnWxZ3cm19_ZHts
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ409VFvihof1TbRcCMCLQUOxPAMVR6NhaY3ApRNTExtBOPfd3ZDtacedyfZx2RnZ77ZmVmAR300qRQxFwWZFDoCFCIKOR4UgSgropTaSpIJzXcOo4mfjl-WyrIDH9tcGFYn9IcVR0SJKlHeG3Zfb_6dWA6Lrayfinfs-nz2EsPhW3RM63VJCu9YhjuLndjmbdtI53z0xmiyivaGbiJWOlBpfV5qPC0smpey2VUq3ikcznC8dXMGnWrNQc_e_r3GwXHYPnlzcMRiNMsaO1s5rM9hEMULNxiaUTIV7MBEoy6SNNa0YmrgXcCD5ya2L-Cc2d8Ws3S-u8DRJXQR_FdXMKSBf1WuyhrybpzniAYqTddIUcqqTkpZv4b-vpFu9pMH0POTMMiCafR6CyeURP2lktKHbvP1Xd2hwm2Ke8anX2zvflk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=NOVEL+ANTI-CLAUDIN18+ANTIBODIES&rft.inventor=XING%2C+Roumei&rft.inventor=YU%2C+Jingfeng&rft.inventor=LU%2C+Hongtao&rft.inventor=QIU%2C+Yangsheng&rft.inventor=GAO%2C+Rui&rft.date=2024-08-15&rft.externalDBID=A1&rft.externalDocID=US2024270839A1